Susceptibility of isolates of Bacteroides to the bactericidal activity of normal human serum. 1979

D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold

Seventy-one strains of species from the Bacteroides fragilis group, including 46 isolates of B. fragilis, were tested for susceptibility to the bactericidal effect of serum from healthy subjects. Twenty-seven (38%) of the isolates were killed by serum. Isolates from feces were significantly more sensitive to serum than were isolates from patients with clinical infections. Killing of bacteria required heat-labile serum components and was an exponential function of serum concentration. Among the various species tested, B. fragilis was clearly the most resistant to bactericidal activity of serum. These observations may be important to the understanding of infections caused by the B. fragilis group, which contains the anaerobes of greatest clinical importance.

UI MeSH Term Description Entries
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D001770 Blood Bactericidal Activity The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST. Activities, Blood Bactericidal,Activity, Blood Bactericidal,Bactericidal Activities, Blood,Bactericidal Activity, Blood,Blood Bactericidal Activities
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001441 Bacteroides fragilis Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.

Related Publications

D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
July 1986, Journal of dental research,
D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
February 1985, The Journal of infectious diseases,
D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
July 1992, FEMS microbiology immunology,
D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
March 1996, Helicobacter,
D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
March 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
December 1984, Journal of medical microbiology,
D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
July 1988, Journal of general microbiology,
D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
November 2000, Journal of medical microbiology,
D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
May 1978, Antimicrobial agents and chemotherapy,
D A Casciato, and J E Rosenblatt, and R Bluestone, and L S Goldberg, and S M Finegold
November 1993, Infection and immunity,
Copied contents to your clipboard!